• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Praxis Precision Medicines to Participate in Upcoming Conferences

By: Praxis Precision Medicines, Inc. via GlobeNewswire
May 20, 2025 at 08:00 AM EDT

BOSTON, May 20, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be participating in three upcoming investor conferences:

  • Praxis management will be participating in a fireside chat at the H.C. Wainwright 3rd Annual BioConnect Investor Conference, taking place at NASDAQ on Tuesday, May 20th, at 9:30am ET. A webcast of the fireside chat will be available through this link.
  • Praxis management will also be participating in the Mizuho Neuro & Ophthalmology Summit, taking place in New York City on Wednesday, May 21st.
  • Praxis management will also be presenting a corporate overview at the Jefferies Global Healthcare Conference, taking place at the Marriott Marquis in New York City on Wednesday, June 4th, at 8:10am ET. A live webcast of the presentation will be available through this link.

The Company will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings.

Replays of the webcasted events will also be available through the “Events & Presentations” page under the “Investors + Media” section of the company’s website for 90 days.

About Praxis
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying genetic insights to the discovery and development of therapies for rare and more prevalent neurological disorders through our proprietary small molecule platform, Cerebrum™, and antisense oligonucleotide (ASO) platform, Solidus™, using our understanding of shared biological targets and circuits in the brain. Praxis has established a diversified, multimodal CNS portfolio including multiple programs across epilepsy and movement disorders, with four clinical-stage product candidates. For more information, please visit www.praxismedicines.com and follow us on Facebook, Instagram, LinkedIn and Twitter/X.


Investor Contact:
Praxis Precision Medicines
investors@praxismedicines.com
857-702-9452

Media Contact:
Dan Ferry
Life Science Advisors
Daniel@lifesciadvisors.com
617-430-7576

Primary Logo

More News

View More
Why the American Eagle Stock Rally Isn't Just Speculation
July 28, 2025
Via MarketBeat
Topics Government World Trade
Tickers AEO ANF GAP
D-Wave, SuperQ, and Verge: A New Path Forward for Quantum?
July 28, 2025
Via MarketBeat
Tickers QBTS
4 Stocks Planning to Substantially Boost Buybacks After Solid Q2
July 28, 2025
Via MarketBeat
Tickers BAC DHI SCHW TDY
3 Reasons Tesla's Post-Earnings Hangover Looks Like a Buy
July 28, 2025
Via MarketBeat
Tickers TSLA
Taiwan Semiconductor Could Boom on This AI Action Plan
July 28, 2025
Via MarketBeat
Topics Artificial Intelligence Government
Tickers NVDA TSM
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap